A Randomized, Open-label, Single-dose, 2-period, 2-sequence, Crossover, Phase 1 Study to Evaluate the Effect of Cyclosporine, a P-glycoprotein, Breast Cancer Resistance Protein, and Organic-anion-transporting Polypeptide Inhibitor, on the Pharmacokinetics of Pimodivir in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Apr 2019
Price : $35 *
At a glance
- Drugs Pimodivir (Primary) ; Ciclosporin
- Indications Influenza A virus infections
- Focus Pharmacokinetics
- Sponsors Janssen-Cilag
- 26 Apr 2019 Status changed from active, no longer recruiting to completed.
- 19 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 19 Feb 2019 Planned End Date changed from 25 Feb 2019 to 12 Mar 2019.